Author/Authors :
Yukumi، Shungo نويسنده General Thoracic Surgeon, National Hospital Organization Ehime Medical Center, Ehime, Japan Yukumi, Shungo , Suzuki، Hideaki نويسنده , , Ishimaru، Kei نويسنده General Surgeon, National Hospital Organization Ehime Medical Center, Ehime, Japan Ishimaru, Kei , Abe، Masahiro نويسنده Pulmonologist, National Hospital Organization Ehime Medical Center, Ehime, Japan Abe, Masahiro , Ichiki، Hiraku نويسنده Pulmonologist, National Hospital Organization Ehime Medical Center, Ehime, Japan Ichiki, Hiraku , Ueda، Seiya نويسنده Pulmonologist, National Hospital Organization Ehime Medical Center, Ehime, Japan Ueda, Seiya , Watanabe، Akira نويسنده , , Sato، Chika نويسنده Pulmonologist, National Hospital Organization Ehime Medical Center, Ehime, Japan Sato, Chika
Abstract :
Introduction: The treatment of complicated parapneumonic effusion (PPE) and
thoracic empyema (TE) is controversial; and the choice of treatment after
confirming the failure of simple drainage remains unclear. The purpose of this
study was to compare the outcomes of intrapleural urokinase (UK)
administration and video-assisted thoracoscopic surgery (VATS) as initial
treatment options for PPE and TE.
Materials and Methods: We retrospectively reviewed and compared the data of
20 patients with PPE and TE diagnosed between January 2010 and December
2012 at our hospital, dividing them on the basis of the initial treatment into a
video-assisted thoracoscopic surgery (VATS) group (n=9) and UK group (n=11).
Results: Age was the only statistically different parameter between both groups
(P=0.025); with the mean age of the VATS and UK groups being 64 and 76 years,
respectively. There was no significant difference in the duration of drainage or
success rate between the UK or VATS groups. Although no statistically significant
differences (P=0.20) were observed, duration of hospital stay was longer in the
UK group (21 and 28 day for VATS and UK, respectively).
Conclusion: VATS for PPE and TE may shorten the duration of hospital stay.
However, UK administration may be used for selective patients because it is
considered to yield outcomes similar to VATS.